Susan Haigney - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Susan Haigney's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Susan Haigney
Verified
Managing Editor, Pharmaceutical Technology
Beats
Any topics relevant to the Emergency Medical Services industry
Consumer health news.
Content
By Felicity Thomas Verified, Susan Haigney Verified| BioPharm International Verified The post-COVID-19 era has seen the consequences of ambitious programs launched during the pandemic, according to Erik Wiklund, CEO of Circio, such as a lack of capital for small biotech and employee layoffs, and Wiklund sees this impacting the industry during 2025. “Many companies launch great ambitions, large valuations
By Susan Haigney Verified| BioPharm International Verified Bristol Myers Squibb (BMS) announced on April 11, 2025 that FDA has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first-line treatment for unresectable or metastatic hepatocellular carcinoma (HCC). According to BMS, HCC is the most common primary liver cancer. The approval was based on results from the global Phase III randomized, open-label CheckMate-9DW trial
Company Info
Pharmaceutical Technology
Medical Device Network is an industry information platform focused on the medical device sector. It provides news, analysis, and directories related to medical device supply chains, regulatory issues, and market trends. The platform serves as a resource for professionals in the industry, offering insights and listings of medical device manufacturers and service providers. Its revenue model likely includes advertising and lead generation through company profiles and sector reports.
London, United Kingdom
+1 646-625-7388